Urology · Baton Rouge, LA
NPI
1689634099
Since 2006
Specialty
Urology
Code 208800000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
7777 Hennessy Blvd, Suite 2004
Baton Rouge, LA, 70808
Phone (225) 769-2500
Groups this clinician bills Medicare through
Medicare paid, 2024
$264K
14,467 services
Medicare patients, 2024
722
Average age 74
Drug cost, 2024
$528K
6,893 prescriptions
Company payments, 2025
$1,192
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stephen R Vick was code Q9967 (low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml), 5,975 times for 57 patients. In total Stephen R Vick billed 14,467 services in 108 codes, and Medicare paid $264K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-10.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 5,975 | 57 | $0.10 | $622 |
| Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | Office | 2,310 | 23 | $0.27 | $631 |
| 81001 Clinical Chemistry | Office | 897 | 568 | $3.06 | $2,746 |
| 99213 Office E&M - Established | Office | 616 | 422 | $59.87 | $37K |
| 36415 Venipuncture Blood Collection | Office | 544 | 394 | $8.56 | $4,658 |
| 84153 Clinical Chemistry | Office | 495 | 362 | $17.82 | $8,823 |
| 99214 Office E&M - Established | Office | 378 | 306 | $87.21 | $33K |
| 76775 Ultrasound - Abdomen and Pelvis | Office | 214 | 186 | $39.43 | $8,439 |
| 74018 Standard X-ray | Office | 146 | 81 | $19.57 | $2,858 |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 134 | 14 | $138.63 | $19K |
| 96372 Injection Administration | Office | 96 | 19 | $9.29 | $892 |
| 87086 Bacterial Culture | Office | 78 | 52 | $7.91 | $617 |
| 52000 Cystourethroscopy | Office | 77 | 67 | $163.89 | $13K |
| 99223 Hospital E&M - Initial | Facility | 64 | 61 | $129.00 | $8,256 |
| 80048 Clinical Chemistry | Office | 60 | 57 | $8.15 | $489 |
By year: 2022 $261K for 12,670 services; 2023 $232K for 12,230 services; 2024 $264K for 14,467 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81001 Clinical Chemistry | 897 | 568 | $3.06 | $2,746 |
| 36415 Venipuncture Blood Collection | 544 | 394 | $8.56 | $4,658 |
| 84153 Clinical Chemistry | 495 | 362 | $17.82 | $8,823 |
| 87086 Bacterial Culture | 78 | 52 | $7.91 | $617 |
| 80048 Clinical Chemistry | 60 | 57 | $8.15 | $489 |
| 87184 General Laboratory | 51 | 32 | $7.33 | $374 |
| 84403 Clinical Chemistry | 40 | 29 | $25.29 | $1,012 |
| 85025 Blood Count | 39 | 31 | $7.61 | $297 |
| 80053 Clinical Chemistry | 29 | 25 | $10.35 | $300 |
| 88112 Surgical Pathology Examination | 28 | 23 | $28.49 | $798 |
Medicare prescription drug claims, 2024
In 2024, the drug Stephen R Vick prescribed most often to Medicare patients was Tamsulosin Hcl, with 2,027 prescriptions and refills. In total Stephen R Vick wrote 6,893 Medicare prescriptions that cost $528K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 2,027 | 4,029 | 483 | $26K |
| Oxybutynin Chloride Er Oxybutynin Chloride | 671 | 1,233 | 166 | $9,753 |
| Nitrofurantoin Nitrofurantoin Macrocrystal | 518 | 666 | 131 | $16K |
| Finasteride Generic | 292 | 667 | 70 | $2,948 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 283 | 471 | 64 | $6,597 |
| Ciprofloxacin Hcl Generic | 273 | 288 | 189 | $2,184 |
| Trimethoprim Generic | 245 | 303 | 40 | $8,651 |
| Myrbetriq Mirabegron | 220 | 290 | 44 | $128K |
| Levofloxacin Generic | 199 | 199 | 159 | $568 |
| Imipramine Hcl Generic | 181 | 291 | 39 | $3,178 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 178 | 178 | 139 | $854 |
| Testosterone Cypionate Generic | 162 | 243 | 39 | $7,329 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 113 | 139 | 45 | $692 |
| Amoxicillin Generic | 98 | 142 | 19 | $367 |
| Doxycycline Hyclate Generic | 97 | 105 | 21 | $1,197 |
Brand drugs: 571 claims; generic drugs: 6,310 claims; opioid claims: 227.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stephen R Vick $1,192 ($1,192 in general payments such as food, travel and fees) from 17 companies. The largest payer was Abbvie Inc. with $192.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 13 | $192 |
| Dendreon Pharmaceuticals LLC | 2 | $161 |
| Sumitomo Pharma America, Inc. 4506.T | 6 | $132 |
| Urogen Pharma, Inc. URGN | 3 | $125 |
| Janssen Biotech, Inc. JNJ | 6 | $119 |
| Antares Pharma, Inc. | 4 | $69.77 |
| Ferring Pharmaceuticals Inc. | 4 | $68.7 |
| Kerecis Limited | 4 | $58.67 |
| Pfizer Inc. PFE | 3 | $54.73 |
| Endo USA, Inc. | 3 | $53.91 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.